H.R. 4 · 110th Congress

Part D Medicare Drugs Price bill

Stage
Passed a chamber
Sponsor
John Dingell
Introduced
2007-01-05
Latest action
2007-02-28 · For Previous Action See H.R.4.

Action history

  1. 2007-02-28For Previous Action See H.R.4.
  2. 2007-01-12Passed/agreed to in House: On passage Passed by recorded vote: 255 - 170 (Roll no. 23).
  3. 2007-01-12Motion to reconsider laid on the table Agreed to without objection.
  4. 2007-01-12On passage Passed by recorded vote: 255 - 170 (Roll no. 23).
  5. 2007-01-12On motion to recommit with instructions Failed by the Yeas and Nays: 196 - 229 (Roll no. 22).
  6. 2007-01-12The previous question on the motion to recommit with instructions was ordered without objection.
  7. 2007-01-12Floor Summary: DEBATE - The House proceeded with 10 minutes of debate on the Barton motion to recommit with instructions. The instructions contained in the motion seek to require the bill to be reported back to the House with an amendment inserting provisions assuring continued access to covered part D drugs and pharmacy networks and protection against increasing drug prices for veterans.
  8. 2007-01-12Mr. Barton (TX) moved to recommit with instructions to Ways and Means and Energy and Commerce.
  9. 2007-01-12The previous question was ordered pursuant to the rule.
  10. 2007-01-12DEBATE - Pursuant to the provisions of H. Res. 6, the House proceeded with three hours of debate on H.R. 4.
  11. 2007-01-12Considered pursuant to H. Res. 6.
  12. 2007-01-12Received in the Senate and Read twice and referred to the Committee on Finance.
  13. 2007-01-09Sponsor introductory remarks on measure.
  14. 2007-01-05Introduced in House
  15. 2007-01-05Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  16. 2007-01-05Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.